Interpreting the Benefit of Simvastatin-Ezetimibe in Patients 75 Years or Older-Reply

Affiliations

¹ Cardiovascular Division, Washington University Medical Center, St Louis, Missouri.
² Brigham and Women's Hospital, Boston, Massachusetts.
³ Duke Clinical Research Institute; Duke University, Durham, North Carolina.

Comment

Richard G Bach et al. JAMA Cardiol. 2020.

. 2020 Feb 1;5(2):235-236.

doi: 10.1001/jamacardio.2019.5241.

¹ Cardiovascular Division, Washington University Medical Center, St Louis, Missouri.
² Brigham and Women's Hospital, Boston, Massachusetts.
³ Duke Clinical Research Institute; Duke University, Durham, North Carolina.

No abstract available

Comment on

Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial.
Bach RG, Cannon CP, Giugliano RP, White JA, Lokhnygina Y, Bohula EA, Califf RM, Braunwald E, Blazing MA. Bach RG, et al. JAMA Cardiol. 2019 Sep 1;4(9):846-854. doi: 10.1001/jamacardio.2019.2306. JAMA Cardiol. 2019. PMID: 31314050 Free PMC article. Clinical Trial.
Interpreting the Benefit of Simvastatin-Ezetimibe in Patients 75 Years or Older.
Li D, McCaw ZR, Wei LJ. Li D, et al. JAMA Cardiol. 2020 Feb 1;5(2):235. doi: 10.1001/jamacardio.2019.5200. JAMA Cardiol. 2020. PMID: 31895431 Free PMC article. No abstract available.
Interpreting the Benefit of Simvastatin-Ezetimibe in Patients 75 Years or Older.
Weingärtner O, Sijbrands EJG, Lütjohann D. Weingärtner O, et al. JAMA Cardiol. 2020 Feb 1;5(2):234. doi: 10.1001/jamacardio.2019.5197. JAMA Cardiol. 2020. PMID: 31895451 No abstract available.